Vaccine Immune Recovery After Leukemia

Completed

Conditions studied: Acute Lymphoblastic Leukemia, Pediatric

In brief

This observational study aims to assess recovery of the immune system and immunity to vaccine-preventable diseases in children, adolescents, and young adults who recently completed treatment for acute lymphoblastic leukemia (ALL). Several children's hospitals in the United States are participating in the study, which will enroll up to 100 pediatric participants. The study is intended to determine the rate of infection after leukemia treatment and to inform future studies and recommendations about whether children and adolescents who have leukemia should receive additional vaccine doses or boosters after treatment.

Key facts

Study ID
NCT05622682
Run by
Children's Hospital of Philadelphia
People needed
89
Starts
2022-09-28
Expected to finish
2025-11-30
Last updated by the study team
2026-01-26

Who can join

Age: 3 and older, up to 31. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.